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Background: We examined the effects of the unilateral cortical stimulation on the survival of neurons showing
degenerative changes and compared those in delaying the progression of amyotrophic lateral sclerosis (ALS)
between the unilateral cortical stimulation and the bilateral one in an animal experimental model using mice.
Methods: We used 19 G93A transgenic mice and randomly divided into three groups: the control group (n = 6)
(the implantation of electrodes in the bilateral motor cortex without electrical stimulation), the unilateral stimulation
group (n = 7) (the implantation of electrodes in the unilateral motor cortex with a 24-hour cortical stimulation) and
the bilateral stimulation group (n = 6) (the implantation of electrodes in the bilateral motor cortex with a 24-hour
cortical stimulation).
Results: The mean survival period was significantly longer in the bilateral stimulation group as compared with the
control group (124.33 ± 11.00 days vs. 109.50 ± 10.41 days) (P < 0.05). In addition, on postoperative weeks 11, 12, 13,
14 and 15, the mean Rota-rod score was significantly higher in the unilateral stimulation group as compared with
the control group (P < 0.05). Furthermore, despite a lack of statistical significance, it was the lowest in the bilateral
stimulation group on postoperative weeks 13, 14, 15 and 17. On postoperative weeks 11, 12, 13, 14 and 16, the
mean score of paw-grip endurance was significantly higher in the unilateral stimulation group as compared with
the control group (P < 0.05). Furthermore, despite a lack of statistical significance, it was the lowest in the bilateral
stimulation group on postoperative weeks 13, 14, 15 and 17.
Conclusions: In conclusion, our results indicate that the bilateral epidural cortical stimulation might have a
treatment effect in a murine model of ALS. But it is the limitation that we examined a small number of
experimental animals. Further studies are therefore warranted to establish our results and to identify the optimal
parameters of the epidural cortical stimulation in a larger number of experimental animals.
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Amyotrophic lateral sclerosis (ALS) is one of the fatal
motor neuron diseases, for which there are no estab-
lished treatment modalities. It has been reported that
patients with ALS have a mean survival period of 3–4
years after the onset of symptoms [1]. Its exact etiology
remains uncertain. It has been proposed, however, that it* Correspondence: rmshin01@gmail.com
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unless otherwise stated.may occur as a result of defects in the clearance of
extracellular glutamate because of a marked decrease in
the activity of glial-specific glutamate transporter-1
(GLT-1). With the increased concentrations of extracellu-
lar glutamate, mediating the activation of the N-methyl-D-
aspartate (NMDA) receptor subtype, patients with ALS
are at risks of neuroexcitotoxic cell death in the motor
cortex [2-4]. To date, glutamate-release inhibitors have
been used to treat patients with ALS in a limited scope.
But they are effective in prolonging the survival period to
only several months [5,6].
Several pre-clinical and clinical studies have shown
that the cortical stimulation is effective in delaying the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The location of stimulating and reference electrodes.
The stimulating electrode (line arrow) was implanted on the dura of
the motor cortex and the reference one (dotted line arrow) was
done in the subcutaneous layer of the posterior neck.
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terations in neurotransmitters and neurotrophic factors
released from the motor cortex. Still, however, little is
known about the optimal parameters that are involved
in the cortical stimulation.
It has been reported that low-frequency repetitive
transcranial magnetic stimulation (rTMS) is effective in
delaying the progression of glutamate-mediated neuro-
toxic disease by suppressing the hyperexcitability of the
motor cortex in patients with ALS [8,11]. In addition,
high-frequency rTMS is effective in stimulating the re-
lease of neurotrophic factors, such as brain-derived
neurotrophic factor (BDNF), and thereby has neuropro-
tective effects in patients with ALS [7,9,10]. Our prelim-
inary study showed that an unilateral, epidural anodal
stimulation was effective in delaying the progression of
disease and in preserving the brain functions in a mur-
ine model of ALS [12]. Thus, we have previously found
that symptoms occurred eight days later as compared
with normal controls, but there was no significant differ-
ence in the survival period between the experimental
and control group.
Given the above background, we examined the effects
of the unilateral cortical stimulation on the survival of
neurons showing degenerative changes and compared
those in delaying the progression of ALS between the
unilateral cortical stimulation and the bilateral one in an
animal experimental model using mice.
Methods
Experimental animals
For the current experimental study, we used 19 G93A
transgenic male mice carrying the G93A human SOD1
mutation (Jackson Lab., Bar Harbor, ME, USA). Thus,
SOD1-G93A mice were housed in a controlled animal
husbandry unit at 21 ± 1°C with water ad libitum.
The experimental animals were randomly divided into
three groups:
(1) The control group (n = 6): The mice underwent
implantation of electrodes in the bilateral motor cortex
without electrical stimulation.
(2) The unilateral stimulation group (n = 7): The mice
underwent implantation of electrodes in the unilateral
motor cortex and daily received a 24-hour cortical
stimulation.
(3) The bilateral stimulation group (n = 6): The mice
underwent implantation of electrodes in the bilateral
motor cortex and daily received a 24-hour cortical
stimulation.
We conducted the current experimental study in com-
pliance with guidelines for the Institutional Animal Care
and Use Committee (IACUC) of Wonkwang University.This study was approved by the IACUC of Wonkwang
University (approval number: # WMS-2009-001).
Experimental procedures
We performed operations for all the experimental ani-
mals at 70 ± 3 days after birth. The average body weight
of mice at operation was 25.90 ± 2.25 g. Anesthesia was
achieved by isoflurane (2% induction and 1.5% mainten-
ance, in 80% N2O and 20% O2) administered via a face
mask. The sufficient depth of anesthesia was checked by
the absence of cardiovascular reflexes in response to tail
pinch. To determine the frequency of the cortical stimu-
lation for the movement of the forelimb and/or face,
contralateral to the sites of electrode implantation, we
stimulated the motor cortex of the experimental animals
with a pulse of 1.0 ms in width and 3–5 seconds in dur-
ation and the minimal direct current. Then, we mea-
sured the threshold of movement twice a week.
At the onset of the symptoms, defined as the initial
presentation of the abnormal gait or limb weakness, we
implanted the electrodes and then initiated the cortical
stimulation in the experimental animals. To do this, we
implanted the circular electrode with a diameter of
2.0 mm on the exposed dura of the motor cortex, which
is located anterior 1.5 mm and posterior 0.5 mm to the
bregma and leaves a 1-mm margin from the midline.
We also implanted the reference electrode with a rect-
angular shape of 2.0 × 4.0 mm in size on the subcutane-
ous layer of the posterior neck (Figure 1). We fixed the
electrodes in the skull with screws and a visible-light-
activated dental resin. In the experimental animals, we
connected the stimulating electrode cable to the swivel
conductor, thus attempting to prevent the kinking, and
then to the programmable electrical stimulator (HSRG
Neuro, Cybermedic, Iksan, Korea).
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trical stimulation to the experimental animals at an
amplitude of 50% of the movement threshold, a fre-
quency of 50 Hz and a duration of 220 μs. In addition,
we performed the anodal stimulation for 24 hours.
On postoperative weeks 8, 9, 10, 11, 12, 13, 14, 15, 16,
17 and 18, we performed the Rota-rod test and paw-grip
endurance test for the experimental animals. Then, we
compared the effects on the motor functions between
the three groups.
Histopathologic examinations
To examine the effects of the unilateral cortical stimula-
tion on the survival of neurons, we additionally operated
three mice and then performed the unilateral cortical
stimulation for them at varying frequencies of 2, 50 and
70 Hz. Then, we extracted their brain and spinal cord at
two weeks after the onset of symptoms and performed
histopathologic examinations. To do this, we stained the
motor cortex and spinal cord at the cervical, thoracic and
lumbar levels using the hematoxylin-eosin (H-E) dye.
Statistical analysis
All data was expressed as mean ± SD (SD: standard devi-
ation). We used the analysis of variance (ANOVA) to
compare the variables between the three groups. A
P-value of <0.05 was considered statistically significant.
Results
Baseline characteristics of the experimental animals
The mean disease duration was 9.83 ± 9.00 days, 14.86 ±
7.73 days and 24.00 ± 19.39 days in the correspondingFigure 2 The survival period in each group. The survival period was sig
the control group (P < 0.05).order. But these differences reached no statistical sig-
nificance (P > 0.05). In addition, the mean movement
threshold was 2.50 ± 0.1 V in the control group, 1.83 ±
0.35 V in the unilateral stimulation group and 2.2 ±
0.2 V in the bilateral stimulation group. But these differ-
ences reached no statistical significance (P > 0.05).
As shown in Figure 2, the mean onset of the symp-
toms was 101.00 ± 8.76 days in the control group,
100.86 ± 4.45 days in the unilateral stimulation group
and 102.33 ± 10.97 days in the bilateral stimulation
group. But these differences reached no statistical signifi-
cance (P > 0.05). In addition, the mean survival period
was 109.50 ± 10.41 days, 114.71 ± 8.40 days and 124.33 ±
11.00 days in the corresponding order. These results in-
dicate that it was significantly longer in the bilateral
stimulation group as compared with the control group
(P < 0.05).
Histopathologic findings
As shown in Figure 3, there was no significant difference
in the number of neurons with degenerative changes be-
tween the stimulating and reference sites. This indicates
that the frequency of stimulation with the number of
neurons with degenerative changes.
Rota-rod scores
As shown in Figure 4, the mean Rota-rod score was
264.90 ± 20.68 s in the control group, 300.00 ± 0.00 s in
the unilateral stimulation group and 274.67 ± 17.42 s in
the bilateral stimulation group on postoperative week
11. In addition, on postoperative weeks 11, 12, 13, 14
and 15, it was significantly higher in the unilateralnificantly longer in the bilateral stimulation group as compared with
Figure 3 The histopathologic findings after stimulation on Brain (a), C-spine (b), T-spine (c) and L-spine (d). The stimulating electrode
was implanted on the motor cortex. We stimulated the brain, C-spine, T-spine and L-spine at a frequency of 2 Hz and 50% of the movement
threshold of 1 V (als-1), a frequency of 50 Hz and 50% of the movement threshold of 0.7 V (als-2) and a frequency of 70 Hz and 50% of the
movement threshold of 0.6 V (als-3) for continuously 24 hours. There were no significant differences in the number of neurons showing degenerative
changes between the stimulating and reference sites.
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(P < 0.05). Furthermore, despite a lack of statistical sig-
nificance, it was the lowest in the bilateral stimulation
group on postoperative weeks 13, 14, 15 and 17.
Paw-grip endurance
As shown in Figure 5, on postoperative week 11, the
mean score of paw-grip endurance was 72.85 ± 6.47 s in
the control group, 90.00 ± 0.00 s in the unilateral stimu-
lation group and 65.55 ± 7.63 s in the bilateral stimula-
tion group. On postoperative weeks 11, 12, 13, 14 andFigure 4 Scores of Rota-rod test. There was a significant difference in th
stimulation group on postoperative weeks 11, 12, 13, 14 and 15 (*P < 0.05).16, it was significantly higher in the unilateral stimula-
tion group as compared with the control group (P <
0.05). Furthermore, despite a lack of statistical signifi-
cance, it was the lowest in the bilateral stimulation
group on postoperative weeks 13, 14, 15 and 17.
Discussion
The exact pathogenesis of ALS remains obscure. Ac-
cording to several in vivo and clinical studies, the hyper-
excitability of the motor cortex is involved in its early
onset [13,14]. It arises from the increased excitability ofe score of Rota-rod test between the control group and the unilateral
Figure 5 Scores of paw-grip test. There was a significant difference
in the score of paw-grip test between the control group and the
unilateral stimulation group on postoperative weeks 11, 12, 13, 14 and
16 (*P < 0.05).
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of the cortical inhibitory interneurons due to the brain
dysfunction. Based on the decreased uptake of glutamate
in astrocytes and increased levels of glutamate in the
cerebrospinal fluid, it can be inferred that the neuronal
toxicity might be mediated by excessive glutamate. That
is, due to the presence of excess glutamate, cortical cells
might be vulnerable to the cell death. This leads to the
decreased threshold of the motor cortex in the early
stage of ALS. But there is an increase in it with the pro-
gression of the disease; it may be increased to such an
extent that it cannot elicit motor-evoked potentials. It
can therefore be inferred that patients with late-stage
ALS would have functional deficits due to the decreased
motor function [15].
Recent non-clinical and clinical studies have shown
that both non-invasive and invasive cortical stimulation
can modulate the excitability of glutamatergic circuit in
the motor cortex [16-20]. This has led to the application
of such treatment modalities as TMS, transcranial direct
current stimulation (tDCS) and direct (epidural) cortical
stimulation (DCS) to the recovery of the motor func-
tions in patients with stroke [21-24]. Moreover, the dir-
ect brain stimulation has also been applied to the
treatment of patients with Parkinson’s disease, depres-
sion or epilepsy [25-27]. Because these types of cortical
stimulation may cause alterations in the neurotransmit-
ters such as glutamate, they are used to treat several
neurological disorders such as stroke, depression, central
pain syndrome, ALS and Parkinson’s disease.
In the current study, we evaluated the effects of epi-
dural cortical stimulation in a murine model of ALS. We
found that the bilateral epidural cortical stimulation de-
layed the progression of ALS. Our results also showed,
however, that scores of Rota-rod and paw-grip tests weresignificantly higher in the unilateral stimulation group as
compared with the control group. Many previous studies
have demonstrated that both the invasive and non-
invasive cortical stimulation are effective in delaying the
progression of ALS. But we failed to clarify the actual
mechanisms by which the cortical stimulation delays it.
We assume that the epidural stimulation of the motor
cortex may modulate the excitability of the motor cortex
and thereby protect the motor neurons from damages
by altering neurotransmitters, such as BDNF, and the
glutamatergic or GABAnergic transmission.
The survival rate was the highest in the bilateral
stimulation group. As compared with the unilateral
stimulation group, however, scores on the behavioral test
were significantly lower in the bilateral one. It can there-
fore be concluded that bilateral cortical stimulation
more strongly affected inter-hemispheric inhibition, thus
producing a decrease in overall motor functions. In
addition, it is possible that bilateral placement of elec-
trodes and wiring could cause the unexpected result of
lesser functional improvement despite the prolonged
survival period. It is also important to recognize that a
prolonged survival period in mice might not be inter-
preted in the same way in humans based on a genomic
response in murine models [28,29].
In the current study, we analyzed the positive effects
of unilateral cortical stimulation based on histopatho-
logical findings. But there were no significant differences
in the number of neurons showing degenerative changes
between the stimulating and reference sites in the motor
cortex and the spinal cord at the cervical, thoracic and
lumbar levels. These results indicate that the unilateral
cortical stimulation affects both sides of the central ner-
vous system.
In the current study, we stimulated the motor cortex
at a frequency of 50 Hz. In addition, we also found that
the epidural cortical stimulation was also effective in
making a recovery of the stroke [23,30]. Furthermore, it
has also been reported that it was effective in increasing
the density of dendrites in the layer V and eliciting
polysynaptic-evoked potentials to a greater extent when
its frequency was 50 or 100 Hz in animal experimental
models using rats or primates [31-34]. Taken together,
we assume that there is a possible relationship between
the progression of ALS and the anatomical and physio-
logical changes in the motor cortex in a murine model
of ALS.
In the current study, we stimulated our experimental
animals for 24 hours a day. It is impossible to continu-
ously perform the TMS for long periods of time. In a
clinical setting, however, it is possible to perform the
TMS using the implantable electrical stimulator with im-
planted epidural electrode in patients with ALS. It would
be an invasive procedure to implant the electrode and
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the sites of stimulation both exactly and continuously.
We first attempted to examine the effects of epidural
cortical stimulation in a murine model of ALS. As com-
pared with other several non-invasive methods, such as
the concentration of the stimulation, the minimization
of the stimulation intensity and the concurrent multi-
focal stimulation, epidural cortical stimulation has bene-
ficial neuromodulatory effects on the brain. But further
studies are warranted to develop advanced treatment
modalities for patients with brain diseases.
Conclusions
In conclusion, our results indicate that the bilateral epi-
dural cortical stimulation might have a treatment effect
in a murine model of ALS. But it is the limitation that
we examined a small number of experimental animals.
Further studies are therefore warranted to establish our
results and to identify the optimal parameters of the epi-
dural cortical stimulation in a larger number of experi-
mental animals.
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